325 related articles for article (PubMed ID: 21597377)
1. Molecular imaging in sarcoidosis.
Mañá J; Gámez C
Curr Opin Pulm Med; 2011 Sep; 17(5):325-31. PubMed ID: 21597377
[TBL] [Abstract][Full Text] [Related]
2. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features.
Soussan M; Augier A; Brillet PY; Weinmann P; Valeyre D
Clin Nucl Med; 2014 Feb; 39(2):e146-59. PubMed ID: 23579973
[TBL] [Abstract][Full Text] [Related]
3. The role of positron emission tomography-computed tomography/magnetic resonance imaging in the management of sarcoidosis patients.
Promteangtrong C; Salavati A; Cheng G; Torigian DA; Alavi A
Hell J Nucl Med; 2014; 17(2):123-35. PubMed ID: 25097898
[TBL] [Abstract][Full Text] [Related]
4. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ
Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446
[TBL] [Abstract][Full Text] [Related]
5. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
Wisenberg G; Thiessen JD; Pavlovsky W; Butler J; Wilk B; Prato FS
J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
[TBL] [Abstract][Full Text] [Related]
6. Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET.
Keijsers RG; Grutters JC; Thomeer M; Du Bois RM; Van Buul MM; Lavalaye J; Van Den Bosch JM; Verzijlbergen FJ
Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):66-71. PubMed ID: 21242947
[TBL] [Abstract][Full Text] [Related]
7. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
[TBL] [Abstract][Full Text] [Related]
8. FDG PET for gauging of sarcoid disease activity.
Adams H; Keijsers RG; Korenromp IH; Grutters JC
Semin Respir Crit Care Med; 2014 Jun; 35(3):352-61. PubMed ID: 25007087
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis.
Matoh F; Satoh H; Shiraki K; Odagiri K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Cardiol; 2008 Jun; 51(3):179-88. PubMed ID: 18522793
[TBL] [Abstract][Full Text] [Related]
10. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.
Sobic-Saranovic D; Grozdic I; Videnovic-Ivanov J; Vucinic-Mihailovic V; Artiko V; Saranovic D; Djuric-Stefanovic A; Masulovic D; Odalovic S; Ilic-Dudvarski A; Popevic S; Pavlovic S; Obradovic V
J Nucl Med; 2012 Oct; 53(10):1543-9. PubMed ID: 22879080
[TBL] [Abstract][Full Text] [Related]
11. Ocular sarcoidosis: does (18)F-FDG PET/CT have any role?
Jung RS; Mittal BR; Maturu NV; Kumar R; Bhattacharya A; Gupta D
Clin Nucl Med; 2014 May; 39(5):464-6. PubMed ID: 24662648
[TBL] [Abstract][Full Text] [Related]
12. Imaging in sinonasal sarcoidosis: CT, MRI, 67Gallium scintigraphy and 18F-FDG PET/CT features.
Braun JJ; Imperiale A; Riehm S; Veillon F
J Neuroradiol; 2010 Jul; 37(3):172-81. PubMed ID: 19959235
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis.
Umeda Y; Demura Y; Morikawa M; Ameshima S; Tsuchida T; Fujibayashi Y; Okazawa H; Ishizaki T
Respirology; 2011 May; 16(4):713-20. PubMed ID: 21382131
[TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study.
Ambrosini V; Zompatori M; Fasano L; Nanni C; Nava S; Rubello D; Fanti S
Clin Nucl Med; 2013 Apr; 38(4):e171-7. PubMed ID: 23429384
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
[TBL] [Abstract][Full Text] [Related]
16. FDG PET imaging in sarcoidosis.
Sobic-Saranovic D; Artiko V; Obradovic V
Semin Nucl Med; 2013 Nov; 43(6):404-11. PubMed ID: 24094707
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
Yokoyama R; Miyagawa M; Okayama H; Inoue T; Miki H; Ogimoto A; Higaki J; Mochizuki T
Int J Cardiol; 2015 Sep; 195():180-7. PubMed ID: 26043154
[TBL] [Abstract][Full Text] [Related]
18. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Skali H; Schulman AR; Dorbala S
Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
[TBL] [Abstract][Full Text] [Related]
19. Imaging the inflammatory activity of sarcoidosis.
Keijsers RG; van den Heuvel DA; Grutters JC
Eur Respir J; 2013 Mar; 41(3):743-51. PubMed ID: 23018903
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
